Withdrawal from the Australian Market

5 September 2019

PROMISIA INTEGRATIVE LIMITED – Withdrawal from the Australian Market

Promisia Integrative Ltd (NZX:PIL) advises that it has entered into a recall action agreement with the
Australian Therapeutic Goods Administration (TGA) to undertake a retail recall of Arthrem joint support
capsules.
Arthrem was supplied to one national pharmacy group and several smaller pharmacy chains and
independent pharmacies in New South Wales. All pharmacies supplied with Arthrem since its launch in
Australia in early 2018 will be contacted in the next 48 hours and asked to return any stock to the
wholesale supplier.
The company has advised in earlier announcements to NZX that it has withdrawn Arthrem from wholesale
distribution in Australia. There is a limited number of Arthrem bottles at the retail level in Australia.
The company has also requested voluntary cancellation of the Arthrem entry in the Australasian Register
of Therapeutic Goods which removes the requirement for registration of Arthrem as a listed
complimentary medicine.
The TGA has requested this action in view of the reported adverse reactions in New Zealand. Both the TGA
and the company note that there have not been any adverse reactions to Arthrem in Australia. The action
is precautionary and based on adverse reactions reported in New Zealand, many of which the company
disputes were as a result of taking Arthrem.


Rene de Wit
CEO
021 571000